Press Releases

Women’s Health Devices Market Sales to Reach USD 62.34 Billion By 2030

Share This Article

The women’s health devices market sales was valued at approximately USD 30.86 billion in 2021, and it is expected to witness a revenue of USD 62.34 billion in 2030, with a CAGR of 8.1% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030.

The women’s health devices market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1492

A strong growth in the women’s healthcare expenditure has been witnessed across the globe. The growing focus on the women’s healthcare coupled with the increased personal disposable income of the women has fostered the growth of the women’s health devices market across the globe. The rising participation of the women in the workforce especially in the developed nations has significantly contributed towards the growth of the market. Moreover, the rising prevalence of chronic diseases like cancer, cardiovascular diseases, and diabetes among the women population is fueling the growth of the global women’s health devices market.

According to the International Agency for Research on Cancer, the female breast cancer has become the most diagnosed type of cancer by surpassing the lungs cancer. Around 2.3 million new cases of breast cancer were reported in 2020. Around 9.2 million new cases of cancer and 4.4 million cancer deaths in female were reported in 2020. These numbers are boosting the healthcare expenditure in the women’s health devices.

Coverage of the Womens Health Devices Market

Report Highlights Details
Market Size US$ 62.3 Billion by 2030
Growth Rate CAGR of 8.1% from 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Product, Application, Region

Competitive Intelligence

The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.

Some of the prominent players in the global women’s health devices market are listed as below:

  • GE Healthcare
  • F. Hoffmann-La Roche
  • Hologic
  • Koninklijke Philips
  • Siemens AG
  • Prestige Consumer Healthcare, Inc.
  • Abbott Laboratories
  • Caldera Medical
  • MedGyn Products
  • Medline Industries
  • Carestream Health

North America to Lead Backed by Rising Healthcare Spending by Companies

North America held the largest women’s health devices market share and was worth USD 16+ billion in 2020 and is probable to be measured as the biggest market in the forthcoming years. Hefty healthcare spending for women’s health in the region, united with the reasonably higher demand for technologically innovative gadgets in the region, are a few of the features that are liable for the domination of this region.

Europe generated the second-largest share in 2020 in the market, which is credited to the sturdy female healthcare expenditure in crucial European nations, coupled with the existence of a considerable female populace in Europe.

Asia Pacific region is projected to observe the highest CAGR during the forecast period of 2021-2030. The enhancement in healthcare substructure in Asian countries, increasing incidence of women’s diseases, and the escalating consciousness regarding technologically progressive women’s health devices are navigating the market growth in the region.

Segments Covered in the Report

By Type

  • Devices
  • Consumables

By Product

  • Surgical
  • Diagnostics
  • Contraceptives
  • Labor & Delivery
  • Critical Care
  • Others

By Application

  • Chronic Diseases
  • General Health
  • Reproductive Health
  • Pelvic & Uterine Health
  • Cancer
  • Infectious Disease
  • Uterine Fibroids
  • Others

By End User

  • Hospitals & Clinics
  • Home Healthcare
  • Obstetrics & Gynecology Clinics
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Others

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Market Scope

  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • The report reviews the major players involved in the development of Women’s Health Devices and list all their pipeline projects
  • Extensive coverage of the Women’s Health Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • Recent developments in the segment / industry

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Women’s Health Devices Market 

5.1. COVID-19 Landscape: Women’s Health Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Women’s Health Devices Market, By Product

8.1. Women’s Health Devices Market, by Product Type, 2021-2030

8.1.1. Surgical

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Diagnostics

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Contraceptives

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Labor & Delivery

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Critical Care

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Women’s Health Devices Market, By Type

9.1. Women’s Health Devices Market, by Type, 2021-2030

9.1.1. Devices

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Consumables

9.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Women’s Health Devices Market, By Application Type 

10.1. Women’s Health Devices Market, by Application Type, 2021-2030

10.1.1. Chronic Diseases

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. General Health

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Reproductive Health

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Pelvic & Uterine Health

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Cancer

10.1.5.1. Market Revenue and Forecast (2019-2030)

10.1.6. Infectious Disease

10.1.6.1. Market Revenue and Forecast (2019-2030)

10.1.7. Uterine Fibroids

10.1.7.1. Market Revenue and Forecast (2019-2030)

10.1.8. Others

10.1.8.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Women’s Health Devices Market, By End User Type 

11.1. Women’s Health Devices Market, by End User Type, 2021-2030

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Home Healthcare

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Obstetrics & Gynecology Clinics

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Diagnostic Laboratories

11.1.4.1. Market Revenue and Forecast (2019-2030)

11.1.5. Ambulatory Surgical Centers

11.1.5.1. Market Revenue and Forecast (2019-2030)

11.1.6. Others

11.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Women’s Health Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.2. Market Revenue and Forecast, by Type (2019-2030)

12.1.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Type (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Type (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.2. Market Revenue and Forecast, by Type (2019-2030)

12.2.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Type (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Type (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Type (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Type (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.2. Market Revenue and Forecast, by Type (2019-2030)

12.3.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Type (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Type (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Type (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Type (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.2. Market Revenue and Forecast, by Type (2019-2030)

12.4.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Type (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Type (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Type (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Type (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.2. Market Revenue and Forecast, by Type (2019-2030)

12.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Type (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Type (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Application Type (2019-2030)

12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

Chapter 13. Company Profiles

13.1. GE Healthcare

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. F. Hoffmann-La Roche

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Hologic

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Koninklijke Philips

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Siemens AG

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Prestige Consumer Healthcare, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Abbott Laboratories

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Caldera Medical

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. MedGyn Products

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Medline Industries

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. Carestream Health

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global women’s health devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for women’s health devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable. 

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1492

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button